Comparison of three commercial one-dose porcine circovirus type 2 (PCV2) vaccines on PCV2 shedding in semen from experimentally infected boars

Veterinary Microbiology

Volumn 164, Issue 1-2, 2013, Pages 145-149

  Seo, Hwi Won ^a   Han, Kiwon ^a   Oh, Yeonsu ^a   Kang, Ikjae ^a   Park, Changhoon ^a   Chae, Chanhee ^a  

^a Seoul National University   (South Korea)

Author keywords

Boar; Commercial porcine circovirus type 2 vaccine; Porcine circovirus type 2; Semen

Indexed keywords

CIRCOVIRUS TYPE 2 VACCINE; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS VACCINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; INOCULATION; MALE; NONHUMAN; SEROLOGY; SPERM; SWINE; VACCINATION; VIRUS SHEDDING;

ANIMALS; CIRCOVIRIDAE INFECTIONS; CIRCOVIRUS; MALE; SEMEN; SWINE; SWINE DISEASES; VIRAL VACCINES; VIREMIA; VIRUS SHEDDING;

PORCINE CIRCOVIRUS 2;

EID: 84875865067     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2013.01.046     Document Type: Article

References (20)

1. Alberti K.A., Estienne M.J., Meng X.J. Effect of vaccination of boars against porcine circovirus type 2 on ejaculate characteristics, serum antibody titers, viremia, and semen virus shedding. J. Anim. Sci. 2010, 89:1581-1587.
2. Chae C. A review of porcine circovirus 2-associated syndromes and diseases. Vet. J. 2005, 169:326-336.
3. Chae C. Porcine circovirus type 2 and its associated disease in Korea. Virus Res. 2012, 164:107-113.
4. Chae C. Commercial porcine circovirus type 2 vaccines: efficacy and clinical application. Vet. J. 2012, 194:151-157.
5. Dupont K., Nielsen E.O., Baekbo P., Larsen L.E. Genomic analysis of PCV2 isolates from Danish archives and a current PMWS case-control study supports a shift in genotypes with time. Vet. Microbiol. 2008, 128:56-64.
6. Fort M., Sibila M., Perez-Martin E., Nofrarias M., Mateu E., Segalés J. One dose of a porcine circovirus 2 (PCV2) sub-unit vaccine administered to 3-week-old conventional piglets elicits cell-mediated immunity and significantly reduces PCV2 viremia in an experimental model. Vaccine 2009, 27:4031-4037.
7. Fraile L., Grau-Roma L., Sarasola P., Sinovas N., Nofrarias M., Lopez-Jimenez R., Lopez-Soria S., Sibila M., Segalés J. Inactivated PCV2 one shot vaccine applied in 3-week-old piglets: improvement of production parameters and interaction with maternally derived immunity. Vaccine 2012, 30:1986-1992.
8. Gagnon C.A., Del Castillo J.R.E., Music N., Fontaine G., Harel J., Tremblay D. Development and use of a multiplex real-time quantitative polymerase chain reaction assay for detection and differentiation of Porcine circovirus-2 genotypes 2a and 2b in an epidemiological survey. J. Vet. Diagn. Invest. 2008, 20:545-558.
9. Kixmoller M., Ritzmann M., Eddicks M., Saalmuller A., Elbers K., Fachinger V. Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2. Vaccine 2008, 26:3443-3451.
10. Madson D.M., Ramamoorthy S., Kuster C., Pal N., Meng X.J., Halbur P.G., Opriessnig T. Characterization of shedding patterns of porcine circovirus types 2a and 2b in experimentally inoculated mature boars. J. Vet. Diagn. Invest. 2008, 20:725-734.
11. Madson D.M., Patterson A.R., Ramamoorthy S., Pal N., Meng X.J., Opriessnig T. Reproductive failure experimentally induced in sows via artificial insemination with semen spiked with porcine circovirus type 2. Vet. Pathol. 2009, 46:707-716.
12. Madson D.M., Ramamoorthy S., Kuster C., Pal N., Meng X.J., Halbur P.G., Opriessnig T. Infectivity of porcine circovirus type 2 DNA in semen from experimentally-infected boars. Vet. Res. 2009, 40:10.
13. McIntosh K.A., Harding J.C., Parker S., Ellis J.A., Appleyard G.D. Nested polymerase chain reaction detection and duration of porcine circovirus type 2 in semen with sperm morphological analysis from naturally infected boars. J. Vet. Diagn. Invest. 2006, 18:380-384.
14. Opriessnig T., Madson D.M., Schalk S., Brockmeier S., Shen H.G., Beach N.M., Meng X.J., Baker R.B., Zanella E.L., Halbur P.G. Porcine circovirus type 2 (PCV2) vaccination is effective in reducing disease and PCV2 shedding in semen of boars concurrently infected with PCV2 and Mycoplasma hyopneumoniae. Theriogenology 2011, 76:351-360.
15. Opriessnig T., Patterson A.R., Madson D.M., Pal N., Ramamoorthy S., Meng X.J., Halbur P.G. Comparison of the effectiveness of passive (dam) versus active (piglet) immunization against porcine circovirus type 2 (PCV2) and impact of passively derived PCV2 vaccine-induced immunity on vaccination. Vet. Microbiol. 2010, 142:177-183.
16. Pal N., Huang Y.W., Madson D.M., Kuster C., Meng X.J., Halbur P.G., Opriessnig T. Development and validation of a duplex real-time PCR assay for the simultaneous detection and quantification of porcine circovirus type 2 and an internal control on porcine semen samples. J. Virol. Methods 2008, 149:217-225.
17. Pozzi N., Guerin B. Viruses in boar semen: detection and clinical as well as epidemiological consequences regarding disease transmission by artificial insemination. Theriogenology 2005, 63:556-572.
18. Segalés J., Urniza A., Alegre A., Bru T., Crisci E., Nofrarias M., Lopez-Soria S., Balasch M., Sibila M., Xu Z., Chu H.-J., Fraile L., Plana-Duran J. A genetically engineered chimeric vaccine against porcine circovirus type 2 (PCV2) improves clinical, pathological and virological outcomes in postweaning multisystemic wasting syndrome affected farms. Vaccine 2009, 27:7313-7321.
19. Seo H.W., Han K., Kim D., Oh Y., Kang I., Park C., Jang H., Chae C. Effects of an inactivated porcine circovirus type 2 (PCV2) vaccine on PCV2 virus shedding in semen from experimentally infected boars. Clin. Vaccine Immunol. 2011, 18:1091-1096.
20. Shen H.G., Beach N.M., Huang Y.W., Halbur P.G., Meng X.J., Opriessnig T. Comparison of commercial and experimental porcine circovirus type 2 (PCV2) vaccines using a triple challenge with PCV2, porcine reproductive and respiratory syndrome virus (PRRSV), and porcine parvovirus (PPV). Vaccine 2010, 28:5960-5966.